Medicinal Chemistry and Drug Discovery and Development India

Download Brochure MCADDI 2024

MCADDI 2024 PROGRAM

Sunday	Monday	Tuesday	Wednesday	Thursday	Friday
Arrival and Registration	Hit Identification, HTS, Virtual Screening Phenotypic Screening Manjunath Ramarao (Atomic AI, USA)	G-Protein Coupled Receptors Manjunath Ramarao (Atomic AI, USA)	Preclinical to Clinical Translational of ADME and PK/PD Sandya Mandlekar (Genentech, USA)	Designing Around Toxicophores in Drug Discovery Nick Meanwell (Baruch S. Blumberg Institute, USA)	Applications of Heterocycles in Drug Design Nick Meanwell (Baruch S. Blumberg Institute, USA)
	Drug-Like Properties Tom Prisinzano (Univ. of Kentucky)	Lessons in Structure-Based Drug Design Vinnie Stoll (AbbVie, USA)	Prodrugs in Drug Discovery Nick Meanwell (Baruch S. Blumberg Institute, USA)	Targeted Protein Degraders and Molecular Glues Bruce Ellsworth (Ashok Purandare) (Bristol-Myers Squibb, USA)	Case History - Discovery of a first-in-class RAD51:BRCA2 Inhibitor-a Potential Pan-Cancer Drug CSN Murthy, (Satya Pharma Innovation, India)
	Break	Break	Break	Break	Break
	Enzymes, Receptors, and Ion Channels Manjunath Ramarao (Atomic AI, USA)	In-silico Tools for Medicinal Chemists Rachel Lagiakos (Schrodinger, USA)	Introduction to Biologics – Part 1 Rustom Mody (Sun Pharma, India)	Case History - Antibody-Drug Conjugate Case History Nitin Damle* (Sun Pharma, India)	Case History - Discovery and Development of a First-in-Class Macrophage Checkpoint Inhibitor for Cancer Therapy Murali Ramachandra (Aurigene Oncology, India
	Lunch	Lunch	Lunch and Learn Session by Merck Life Sciences	Lunch	Case History - Discovery and Development of a First-in-Class Macrophage Checkpoint Inhibitor for Cancer Therapy Murali Ramachandra (Aurigene Oncology, India
Principles of Medicinal Chemistry and Drug Discovery-1 Tom Prisinzano (Univ. of Kentucky)	Principles of Molecular Interactions Vinnie Stoll (AbbVie, USA)	Case History - Application of In-Silico Rachel Lagiakos (Schrodinger, USA)	Introduction to Biologics – Part 2 Rustom Mody (Sun Pharma, India)	General Introduction to Process Chemistry Martin Eastgate (Bristol-Myers Squibb, USA	Lunch and Learn Session by Agilent Technologies
Principles of Medicinal Chemistry and Drug Discovery-2 Tom Prisinzano (Univ. of Kentucky)	Hit-to Lead and Lead Optimization Bruce Ellsworth (Bristol-Myers Squibb	Bioisosteres in Drug Design Nick Meanwell (Baruch S. Blumberg Institute, USA)	Principles of Antibody-Drug Conjugates and Beyond Nitin Damle* (Sun Pharma, India)	Case History of Integrated Drug Discovery and Process Development – 1 Bruce Ellsworth (Bristol-Myers Squibb, USA)	Case History - Discovery and Development of Fostemsavir Nick Meanwell Baruch S. Blumberg Institute, USA
	Break	Break	Break	Break	Case History : Evolution of HPK1 clinical candidate, GRC 54276: preclinical updates Nagaraj Gowda Glenmark Pharmaceuticals
Target ID and Validation Manjunath Ramarao (Atomic AI, USA)	Case History – Integrated Drug Discovery and Development Mukul Jain (Zydus)	Drug Metabolism and PK and Disposition Sandya Mandlekar (Genentech, USA)	Bio Pharmaceutics Developability Characteristics Sridhar Desikan (Nexus, USA)	Case History of Integrated Process Development – 2 Martin Eastgate (Bristol-Myers Squibb, USA)
Dinner				Banquet and Keynote Lecture	Concluding Remarks William Greenlee MedChem Discovery Consulting LLC, USA